Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Geron Corp. | 16 | 0 | 0 | 0 | €4.49 | €5.57 | 23.959% |
| Genmab A/S | 19 | 0 | 19 | 0 | €241.20 | €275.00 | 14.013% |
| G1 Therapeutics | 21 | 20 | 2 | 19 | €3.19 | €2.75 | -13.739% |
| Formycon AG | 22 | 1 | 19 | 0 | €52.60 | €89.00 | 69.202% |
| Faron Pharmaceuticals Oy | 2 | 1 | 0 | 1 | €1.60 | €6.15 | 285.338% |
| Fagron N.V. | 1 | 0 | 0 | 0 | €18.72 | €20.00 | 6.838% |
| Faes Farma S.A. | 1 | 0 | 0 | 0 | €3.49 | €6.00 | 71.920% |
| EyePoint Pharmaceuticals Inc. | 38 | 1 | 19 | 0 | €9.48 | €23.32 | 146.043% |
| Exelixis Inc. | 20 | 0 | 2 | 0 | €20.89 | €26.01 | 24.492% |
| Exact Sciences | 34 | 0 | 20 | 0 | €45.55 | €53.50 | 17.466% |
| Evolus Inc | 20 | 0 | 11 | 0 | €11.00 | €14.78 | 34.400% |
| Esperion Therapeutis.Inc. | 17 | 11 | 3 | 11 | €2.43 | €7.42 | 205.317% |
| Enanta Pharmaceuticals Inc. | 6 | 4 | 0 | 0 | €14.60 | €25.58 | 75.192% |
| Emergent Biosolutions Inc. | 4 | 3 | 2 | 0 | €10.91 | - | - |
| Eli Lilly Corp. | 82 | 1 | 32 | 1 | €835.80 | €900.00 | 7.681% |
| Eledon Pharmaceuticals Inc. | 13 | 1 | 7 | 1 | €2.34 | €4.00 | 70.940% |
| Dynavax Technologies Corp | 3 | 0 | 1 | 0 | €9.75 | €27.02 | 177.148% |
| Dr. Reddy's Laboratories Ltd. ADR | 6 | 1 | 0 | 0 | €72.00 | €74.65 | 3.674% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.80 | €24.97 | 4.929% |
| Cytokinetics Inc. | 34 | 1 | 2 | 0 | €52.50 | €83.92 | 59.840% |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €73.00 | - | - |
| Corvus Pharmaceuticals Inc | 5 | 1 | 0 | 0 | €1.78 | €6.45 | 262.913% |
| CorMedix Inc | 19 | 0 | 19 | 0 | €4.54 | €6.50 | 43.172% |
| Corcept Therapeutics Inc. | 15 | 0 | 2 | 0 | €30.57 | €36.87 | 20.602% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €53.50 | €50.00 | -6.542% |